Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years Molecular Diagnostics Market | Page 2

Growth in biomarker identification is expected to foster growth of the molecular diagnostics
market
Application of biomarkers in molecular diagnostic is increasing, due to advantages of biomarkers
such as aiding in early detection of specific diseases. For instance, biomarkers are used in
detection of ABO haemolytic diseases in new born, Huntington's disease and hereditary
haemochromatosis, and cystic fibrosis. Biomarkers are also used in detection of disorders related
to chromosome structure such as Turner syndrome, Down syndrome, patau syndrome, and
Edwards’s syndrome. Furthermore, biomarker also have wide application in therapeutic areas,
which includes neurological diseases, metabolic disorders, immune deregulation, and oncology.
Increasing research and development for identification of biomarkers have led to development of
new molecular diagnostic tests, which is expected to foster growth of the molecular diagnostics
market. For instance, in February 2018, FDA granted marketing authorization to Banyan
Biomarkes, Inc. for the first diagnostic blood test, for traumatic brain injury, Banyan BTI. Such
innovations for various disease indication is expected to drive growth of the molecular
diagnostics market in the near future.
Report includes chapters which deeply display the following deliverable
about industry :
Molecular Diagnostics Market Research Objective and Assumption
• Molecular Diagnostics Market Purview - Report Description,
Executive Summary, and Coherent Opportunity Map (COM)
• Molecular Diagnostics Market Dynamics, Regulations, and Trends
Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger
and Acquisitions, New
system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST
Analysis
• Global Molecular Diagnostics Market, By Regions
• Molecular Diagnostics
Market Competition by Manufacturersincluding Production, Share,
Revenue, Average Price, Manufacturing Base